Vir Biotechnology
VIR
Operating Margin for Vir Biotechnology (VIR)
Operating Margin as of April 2024 (TTM): -78.24%
According to Vir Biotechnology 's latest financial reports and stock price the company's current Operating Margin is -78.24%. At the end of 2022 the company had an Operating Margin of 47.72%.
Operating Margin history for Vir Biotechnology from 2019 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 47.72% | -5.64% |
| 2021 | 50.58% | -111.39% |
| 2020 | -444.06% | -98.19% |
| 2019 | -24,546.98% | 83.1% |
| 2018 | -13,405.99% | -75.27% |
| 2017 | -54,212.08% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.